pablo4
$TARA I am very bullish on TARA although I don't see any major price resurgence until spring of next year, most likely.....but what a great time to accumulate now while it's beaten down. Why?
Well, how many small bios have a drug in their pipelines that has proven "curative?" TARA does with TARA-002 to treat LMs. To date, all data shows a curative effect. TARA owns global rights aside from Japan and Taiwan...TARA has responsibility to develop and commercialize TARA-002 globally while Chugai retains rights within Japan and Taiwan where the originator compound, OK-432 (Picibanil) is already approved and standard care for LMs.
TARA is eligible for a valuable PRV upon approval of the BLA it intends to file in the 2nd half of 2027.
I believe this BLA is going to be a major catalyst and cause a major increase in TARA's market cap. JMO
6
